eritoran: Clinical Trials

4 trials of eritoran, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed, 1 recruiting. 2 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 11Terminated 1
Phase 31Recruiting 1

Follow eritoran: new trials by email Literature Review of eritoran trials Research Report on eritoran

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Ceftriaxone + Macrolide, Moxifloxacin or Levofloxacin, Piperacillin-tazobactam + Macrolide - Respiratory Tract Diseases, Influenza (Pandemic)
Phase 3RecruitingUMC Utrecht200002016-04-112026-11-04
The Effect of TLR4 Inhibition in Obese and Type 2 Diabetic Subjects
Eritoran, D5W - Insulin Sensitivity
Phase 2TerminatedThe University of Texas Health Science Center at San Antonio152015-01-012020-03-04
The Role of TLR4 on Lipid-induced Insulin Resistance
Eritoran, D5W (5% Dextrose in water) - Insulin Sensitivity
Phase 2CompletedThe University of Texas Health Science Center at San Antonio102015-01-012019-10-08
A Study of Eritoran (E5564) Administered IV Over 14 Days Prior to and During Bone Marrow Engraftment in BMT Patients Who Have Received Myeloablative Conditioning Treatment and Are Receiving Bone Marrow or Stem Cells From Matched Related Donors
E5564 - Leukemia
Phase 1TerminatedEisai Inc.302008-09-012014-07-11

Conditions studied

Insulin Resistance (2)  ·  COVID-19 (1)  ·  Community-Acquired Pneumonia (1)  ·  Graft vs Host Disease (1)  ·  Influenza, Human (1)  ·  Leukemia (1)  ·  Lung Diseases (1)  ·  Pneumonia (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)

Sponsors

The University of Texas Health Science Center at San Antonio (2)  ·  Eisai Inc. (1)  ·  UMC Utrecht (1)

Countries

United States (4)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Colombia (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Estonia (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  India (1)  ·  Ireland (1)  ·  Israel (1)

Top investigators

Nicolas Musi, MD (2)  ·  Colin McArthur, Dr (1)  ·  Derek Angus, Prof (1)  ·  John Marshall, Prof (1)  ·  Kenneth Cooke (1)  ·  Lennie Derde, MD (1)  ·  Luis Felipe Reyes, MD, MSc, PhD (1)  ·  Marc Bonten, Prof (1)  ·  Steve Webb, Prof (1)

Results publications

PMID 36066991, PMID 32267771, PMID 32876697, PMID 33394942, PMID 33509275, PMID 33631065, PMID 34251506, PMID 34351721, PMID 34351722, PMID 34473343, PMID 34606578, PMID 35315874, PMID 36525245, PMID 36942550, PMID 36967714, PMID 37039790, PMID 37256341, PMID 37489818, PMID 37877585, PMID 37888913, PMID 40261382, PMID 40360262, PMID 42823695

NIH funding

2015 (1), 2023 (1)